Background:
The hyperglycemic state is known to shorten the erythrocyte life span.
Erythrocyte creatine (EC) reflects the mean erythrocyte age and is useful as an indicator of hemolysis. Here, we studied the relationship between EC and glycemic control indicators [HbA1c or glycated albumin (GA)] in non-diabetic subjects and diabetic patients.
Methods:
This study included 119 patients with type 2 diabetes mellitus (T2DM) and 76 non-diabetic subjects matched by sex and age. We studied the relationships between EC and HbA1c or GA in patients with T2DM and non-diabetic subjects.
Results: Erythrocyte creatine in T2DM patients was significantly higher than that in non-diabetic subjects, and the ratio of high EC levels (>1.8 μmol/g Hb) in T2DM patients was significantly higher as well. Furthermore, female EC was significantly higher than male EC, and the ratio of high EC levels in females was significantly higher than in the males as well. While male EC had no significant correlation with HbA1c or GA, female EC had significant positive correlations with both. Male EC had no significant difference between T2DM patients and non-diabetic subjects, while the EC in female patients with T2DM was significantly higher than in female non-diabetic subjects.
Conclusions:
The significant positive correlations of EC with HbA1c and GA in female patients with T2DM suggested that the mean erythrocyte age decreased in female diabetic patients with poor glycemic control.
K E Y W O R D S
erythrocyte creatine, glycated albumin, HbA 1C , hemolysis, type 2 diabetes mellitus treatment for diabetes improves the erythrocyte life span shortened by these effects. 11 It has been demonstrated that hyperglycemia shortens the erythrocyte life span resulting in a negative correlation between HbA1c and the erythrocyte life span. 12 In addition, it was reported that alloxan-induced diabetic mice had a high reticulocyte count, which indicated that the hyperglycemic status induces hemolysis. 13 Because the creatine content in human erythrocytes decreases along with aging of the erythrocytes, the amount of creatine in packed erythrocytes is focused on as an index reflecting the mean erythrocyte age. [14] [15] [16] [17] It is known that patients with hemolytic anemia have high erythrocyte creatine (EC) levels. EC also increases in patients with subclinical hemolysis without anemia and is capable of detecting hemolysis more sensitively than the conventional reticulocyte count or haptoglobin. 18, 19 Here, we studied the relationships between EC and HbA1c or GA in patients with type 2 diabetes mellitus (T2DM) and non-diabetic subjects to study the relationship between EC and the glycemic control status. 
| MATERIAL S AND ME THODS

HbA1c, expressed as a National Glycohemoglobin
Standardization Program (NGSP) value, was measured by highperformance liquid chromatography. 20 GA was determined by the enzymatic method using albumin-specific proteinase, ketoamine oxidase, and albumin assay reagent (Lucica GA-L; Asahi Kasei Pharma Co., Tokyo, Japan).
21
Erythrocyte creatine was measured enzymatically in accordance with a previous report. 22 In brief, the plasma and buffy coat were Serum lactate dehydrogenase (LDH) levels were determined by standard laboratory assays. Blood cell counts, hematocrit, and hemoglobin were measured by an automated hematology system. TA B L E 1 Clinical characteristics of study subjects
| RE SULTS
Clinical characteristics of study subjects are shown in Table 1 . The T2DM patients had significantly higher HbA1c, GA, and the GA/ HbA1c ratio than non-diabetic subjects. The T2DM patients had significantly lower Hb and higher LDH than non-diabetic subjects.
Erythrocyte creatine in T2DM patients was significantly higher than in non-diabetic subjects (1.49 ± 0.33 vs 1.40 ± 0.21 μmol/g Hb; P = 0.034). While only one subject had high EC that exceeded the ref-
erence value (>1.8 μmol/g Hb) in non-diabetic subjects, 20 patients had high EC in T2DM patients, indicating the significantly higher ratio in T2DM patients (P < 0.0001). Correlations of EC with various indices were studied, and a significant negative correlation with sex was observed (0: female; 1: male) (P < 0.0001) suggesting the effect of sex differences on EC (Table 2 ). Furthermore, EC had a significant positive correlation with HbA1c (P = 0.010) and GA (P = 0.036) as well, while EC had no significant correlation with the GA/HbA1c ratio.
Because EC had a significant correlation with sex, comparisons between males and females were made for various data (Table 3) .
EC was significantly higher in females than in males (1.57 ± 0.27 vs 1.37 ± 0.28 μmol/g Hb; P < 0.0001), and the ratio of high EC levels (>1.8 μmol/g Hb) in females was significantly higher than in males (P < 0.001). While male EC had no significant correlation with HbA1c or GA ( Figure 1A ,B), female EC had a significant positive correlation with HbA1c and GA ( Figure 1C,D) . Female EC was significantly higher than male EC in both non-diabetic subjects and T2DM patients ( Figure 2 ).
Furthermore, male EC had no significant difference between non-diabetic subjects and T2DM patients, while female EC was significantly higher in the T2DM patients than in non-diabetic subjects.
| D ISCUSS I ON
Erythrocyte creatine in the T2DM patients was significantly higher than in non-diabetic subjects, and the ratio of high EC levels (>1.8 μmol/g Hb) was significantly higher as well. Female EC was significantly higher than male EC, and the ratio of high EC in females was significantly higher than in males. While male EC had no significant correlation with HbA1c or GA, female EC had significant positive correlations with both of them. The above results suggested that female erythrocytes were more sensitive to fragility induced by hyperglycemia.
Currently, the erythrocyte life span is measured by labeling the patient's erythrocytes with the radioisotopes 51 Cr or 32 P to estimate the apparent half-life based on the attenuation of blood radioactivity. However, these methods require long-term patient constraints by hospitalization and are therefore difficult to perform as routine tests. On the other hand, EC is measured in a simple manner and capable of evaluating the mean erythrocyte age through one single blood sample, which allows an estimation of the mean erythrocyte age. 14-17 EC also increases in patients with subclinical hemolysis and is therefore capable of detecting mild but persistent hemolysis at high sensitivity. 18, 19 Erythrocyte creatine in T2DM patients was significantly higher than in non-diabetic subjects, and EC had significant positive correlations with HbA1c and GA. These results suggested that the increase in EC in patients with poor glycemic control decreased the mean erythrocyte age. That is to say, it was inferred that patients with poor glycemic control have enhanced hematopoiesis associated with excessive erythrocyte destruction from hyperglycemia, in other words, a reduction in the erythrocyte life span. It was considered that hyperglycemia enhanced the vulnerability of the erythrocytes to promote hemolysis, which resulted in a shortened erythrocyte life span in the previous reports as well. 11, 13 It is presumed that the enhanced vulnerability of the erythrocytes by hyperglycemia might be associated with decreasing erythrocyte membrane fluidity due to increments in advanced glycation end products (AGEs) in the erythrocyte membrane. 10 It was also shown that hyperglycemia shortened the erythrocyte life span resulting in falsely low HbA1c. 12 The present study demonstrated that EC could evaluate the possible presence of falsely low HbA1c in a simpler manner.
Female EC was significantly higher than male EC in both diabetic patients and non-diabetic subjects. While male EC showed no significant difference between diabetic patients and non-diabetic subjects, female EC in diabetic patients was significantly higher than in non-diabetic subjects. These results suggested that the higher EC in diabetic patients than in non-diabetic subjects within the overall male and female subjects might be based on higher EC in female diabetic patients. Additionally, while male EC had no significant correlation with HbA1c or GA, female EC had positive correlations with both. It was therefore considered that falsely low HbA1c through a decrease in mean erythrocyte age due to hyperglycemia might readily occur in females but not in males. These results strongly suggested that female erythrocytes were more vulnerable to hyperglycemia than male ones. Sex differences in erythrocyte vulnerability to hyperglycemia are the first observation that had not been reported before. Because most subjects in the present study were 50 years old or older, menstrual bleeding and enhanced hematopoietic ability by estrogen were considered negative as mechanisms of the sexual difference. The reason why sexual differences are involved in erythrocyte vulnerability is still uncertain and should be studied.
TA B L E 2 Correlations of erythrocyte creatine with various parameters
We previously reported that GA was not affected by hemolysis and that the GA/HbA1c increased in patients with hemolysis. 9 In the present study, however, no significant correlation was found between EC and the GA/HbA1c ratio. Falsely low HbA1c was induced through a decreasing mean erythrocyte age, but the GA/HbA1c ratio had no significant correction with EC, which suggested that GA had a falsely low level to a degree similar to that of HbA1c. However, because GA was not affected by a decrease in mean erythrocyte age, it was inferred that GA reduced because of the effect of hyperglycemia. These phenomena are novel observations that have not been reported before. Although the mechanism of falsely low GA induced by hyperglycemic status was uncertain at present, enhanced albumin catabolism, enhanced GA catabolism, or enhanced metabolism from GA to AGEs was presumed to be a possible mechanism. Identification of the mechanism indicated above is awaited.
The present study indicated that hyperglycemia might reduce the mean erythrocyte age through slight hemolysis to elevate EC resulting in falsely low HbA1c only in females. It was also considered that hyperglycemic status might induce falsely low GA similarly to HbA1c. In female diabetic patients, therefore, it is necessary to pay attention to the assessment of glycemic control because deteriorated glycemic control induces falsely low HbA1c and GA. 
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